Plasma and Intrapulmonary Concentrations Study of WCK 5222

Status:
Completed

Trial end date:
2017-07-30

Target enrollment:

Participant gender:

This is a Phase 1, multiple dose, open-label pharmacokinetic study in healthy adult male and female subjects.

Phase 1

Wockhardt